BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3553746)

  • 21. Does lower systemic temperature enhance cardioplegic myocardial protection?
    Grover FL; Fewel JG; Ghidoni JJ; Trinkle JK
    J Thorac Cardiovasc Surg; 1981 Jan; 81(1):11-20. PubMed ID: 7453211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial metabolism and ventricular function following cold potassium cardioplegia.
    Fremes SE; Weisel RD; Mickle DA; Ivanov J; Madonik MM; Seawright SJ; Houle S; McLaughlin PR; Baird RJ
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):531-46. PubMed ID: 3872382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of crystalloid cardioplegia and verapamil on cardiac function and cellular biochemistry during hypothermic cardiac arrest.
    Prasad K; Bharadwaj B
    Can J Cardiol; 1987 Sep; 3(6):293-9. PubMed ID: 2962703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of blood versus crystalloid coronary sinus cardioplegia during global myocardial ischemia.
    Goldstein JP; Salter DR; Murphy CE; Abd-Elfattah AS; Morris JJ; Wechsler AS
    Circulation; 1986 Nov; 74(5 Pt 2):III99-104. PubMed ID: 3769191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
    Rousou JH; Dobbs WA; Engelman RM
    Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful six-hour cardiopulmonary preservation with simple hypothermic crystalloid flush.
    Starkey TD; Sakakibara N; Hagberg RC; Tazelaar HD; Baldwin JC; Jamieson SW
    J Heart Transplant; 1986; 5(4):291-7. PubMed ID: 3305820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury.
    Rosenkranz ER; Okamoto F; Buckberg GD; Robertson JM; Vinten-Johansen J; Bugyi HI
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):428-35. PubMed ID: 3951246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advantages of hypothermic potassium cardioplegia and superiority of continuous versus intermittent aortic cross-clamping.
    Roberts AJ; Abel RM; Alonso DR; Subramanian VA; Paul JS; Gay WA
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):44-58. PubMed ID: 7350388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal intraoperative protection of myocardium distal to coronary stenoses.
    Silverman NA; Schmitt G; Levitsky S; Feinberg H
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial energetics after thermally graded hyperkalemic crystalloid cardioplegic arrest.
    Krukenkamp I; Silverman N; Sorlie D; Pridjian A; Feinberg H; Levitsky S
    J Thorac Cardiovasc Surg; 1986 Jul; 92(1):56-62. PubMed ID: 3724227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of blood-based and asanguineous cardioplegic solutions administered at 4 degrees C. An ultrastructural morphometric study in the dog.
    Axford-Gatley RA; Wilson GJ; Feindel CM
    J Thorac Cardiovasc Surg; 1990 Sep; 100(3):400-9. PubMed ID: 2391975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
    Coetzee A; Kotzé J; Louw J; Lochner A
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved myocardial protection with blood and crystalloid cardioplegia.
    Weisel RD; Fremes SE; Baird RJ; Ivanov J; Madonik MM; Mickle DA
    J Vasc Surg; 1984 Sep; 1(5):656-9. PubMed ID: 6389911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new concept of long-term donor heart preservation: nucleoside transport inhibition.
    Flameng W; Sukehiro S; Möllhoff T; Van Belle H; Janssen P
    J Heart Lung Transplant; 1991; 10(6):990-8. PubMed ID: 1756166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of temperature of cardioplegic solution.
    Behrendt DM; Jochim KE
    J Thorac Cardiovasc Surg; 1978 Sep; 76(3):353-7. PubMed ID: 682667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The time course of myocardial high-energy phosphate degradation during potassium cardioplegic arrest.
    Engelman RM; Rousou JH; Longo F; Auvil J; Vertrees RA
    Surgery; 1979 Jul; 86(1):138-47. PubMed ID: 572100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cold blood as the vehicle for potassium cardioplegia.
    Barner HB; Laks H; Codd JE; Standeven JW; Jellinek M; Kaiser GC; Menz LJ; Tyras DH; Pennington DG; Hahn JW; Willman VL
    Ann Thorac Surg; 1979 Dec; 28(6):509-21. PubMed ID: 518180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A no-flush, core-cooling technique for successful cardiopulmonary preservation in heart-lung transplantation.
    Kontos GJ; Adachi H; Borkon MA; Cameron DE; Baumgartner WA; Hutchins GM; Brawn J; Reitz BA
    J Thorac Cardiovasc Surg; 1987 Dec; 94(6):836-42. PubMed ID: 3119946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of cardioplegia with blood and crystalloid potassium solutions during prolonged aortic cross-clamping.
    Nwaneri NJ; Levitsky S; Silverman NA; Feinberg H
    Surgery; 1983 Nov; 94(5):836-41. PubMed ID: 6635947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influences of cardiopulmonary bypass, temperature, cardioplegia, and topical hypothermia on cardiac innervation.
    Murphy DA; Armour JA
    J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1192-9. PubMed ID: 1597985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.